Evidence map›Paper›PMID 35718091›Full record

ArticleThe Journal of molecular diagnostics : JMD2022

High-Throughput Variant Detection Using a Color-Mixing Strategy.

Nina G Xie, Kerou Zhang, Ping Song, Renqiang Li, Junfeng Luo, David Y Zhang

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of molecular diagnostics : JMD, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 94% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Nina G XieDepartment of Bioengineering, Rice University, Houston, Texas.
Kerou ZhangDepartment of Bioengineering, Rice University, Houston, Texas.
Ping SongDepartment of Bioengineering, Rice University, Houston, Texas.
Renqiang LiResearch and Development, Nuprobe China, Shanghai, China.
Junfeng LuoResearch and Development, Nuprobe China, Shanghai, China.
David Y ZhangDepartment of Bioengineering, Rice University, Houston, Texas; Systems, Synthetic, and Physical Biology, Rice University, Houston, Texas. Electronic address: dyz1@rice.edu.
Rice University · US

Funding

Enrichment of DNA/RNA Sequences based on Pre-equilibrium Hybridization KineticsR01HG008752 · NHGRI · RICE UNIVERSITY · PI VEISEH, OMID · 2016 to 2021
$3.0M
NHGRI NIH HHS R01 HG008752
6 · The paper itself

Abstract

Many diseases are related to multiple genetic alterations within a single gene. Probing for highly multiple (>10) variants in a single quantitative PCR tube is impossible because of a limited number of fluorescence channels and the limited ability to test one variant per channel, increasing the need for tubes. Herein, a novel color-mixing strategy was experimentally validated that uses fluorescence combinations as digital color codes to probe multiple variants simultaneously. The color-mixing strategy relies on a simple intratube assay that can probe for 15 variants as part of an intertube assay that can probe for an exponentially increased number of variants. This strategy is achieved by using multiplex double-stranded toehold probes modified with fluorophores and quenchers; the probes are designed to be quenched or remain luminous after binding to wild-type or variant templates. The color-mixing strategy was used to probe for 21 pathogenic variants in thalassemia and to distinguish between heterozygous and homozygous variants in six tubes, with a specificity of 99% and a sensitivity of 94%. To support tuberculosis diagnosis, the same strategy was applied to simultaneously probe in Mycobacterium tuberculosis for rifampicin-resistance mutations occurring within one 81-bp region and one 48-bp region in the rpoB gene, plus five isoniazid-resistance mutations in the inhA and katG genes.

Indexed as

Mycobacterium tuberculosisTuberculosisAntitubercular AgentsBacterial ProteinsHumansIsoniazidMicrobial Sensitivity TestsMutationRifampinAntitubercular AgentsBacterial ProteinsIsoniazidRifampin

Identifiers

PMID35718091
PMCPMC9379672
OpenAlexW4282981017

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.